Ajanta Pharma

Ajanta Pharma EBIT per Share

The EBIT per Share of Ajanta Pharma (AJANTPHARM.NS) as of Oct 19, 2026 is 111.43 INR. In the previous year, EBIT per Share was 96.84 INR — a change of 15.06% (higher).

EBIT per Share

111.43INR

YoY

15.06%

Last updated:

EBIT per Share of Ajanta Pharma is 2026 111.43 INR. EBIT per Share of Ajanta Pharma was 2025 96.84 INR. It decreases by 15.06% higher compared to the previous year.

The Ajanta Pharma EBIT per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT per Share
Date
EBIT per Share
Jan 1, 2023
59.61 INR
Jan 1, 2024
89.50 INR
Jan 1, 2025
96.84 INR
Jan 1, 2026
111.43 INR
Jan 1, 2027 (e)
131.50 INR
Jan 1, 2028 (e)
153.29 INR
Jan 1, 2029 (e)
174.70 INR
Jan 1, 2030 (e)
167.07 INR
The Ajanta Pharma EBIT per Share history
YEAREBIT per ShareYoY
est167.07INR-4.37%
est174.70INR+13.96%
est153.29INR+16.57%
est131.50INR+18.02%
111.43INR+15.06%
96.84INR+8.21%
89.50INR+50.13%
59.61INR-16.95%
71.78INR+2.59%
69.96INR+34.38%
52.07INR+35.52%
38.42INR-16.45%
45.98INR-8.77%
50.40INR+20.97%
41.67INR+21.22%
34.37INR+39.73%
24.60INR+14.68%
21.45INR+71.12%
12.54INR+110.79%
5.95INR+30.14%
4.57INR+9.99%
4.15INR+15.43%
3.60INR+41.81%
2.54INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Ajanta Pharma Stock analysis

What does Ajanta Pharma do? Ajanta Pharma Ltd is an Indian pharmaceutical company founded in 1973 by Madhukar Alva and has since become a leading company in the global pharmaceutical industry. Ajanta Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ajanta Pharma stock

EBIT per Share of Ajanta Pharma is 111.43 INR in 2026.

EBIT per Share of Ajanta Pharma changed from 96.84 INR to 111.43 INR, representing a 15.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EBIT per Share Ajanta Pharma since 2006 – with annual values, charts, and detailed analysis.

EBIT per Share measures operating profit allocated to each outstanding share.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Ajanta Pharma

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Ajanta Pharma